Industry

Oura acquires Counsel Health for $625M, pivots to AI-powered clinical care

Oura's $625M acquisition of Counsel Health signals a strategic shift from wearable-only hardware toward integrated telehealth and AI diagnostics, even as the company postpones its IPO.

Last verified:

Oura’s $625M bet on clinical AI integration

Oura announced on November 10 that it is acquiring Counsel Health, an AI-powered telemedicine startup, for $625 million. According to TechCrunch AI, the deal positions Oura to expand beyond wearable analytics into physician-coordinated preventative and chronic care—a significant pivot as competition in the smart ring market intensifies and the company’s planned IPO remains shelved.

Counsel Health, which already integrates into the Oura app since June, combines machine-learning diagnostics with access to licensed clinicians. The platform allows users to query an AI medical assistant and escalate to a physician for prescriptions, lab result interpretation, and specialist referrals—all without leaving the Oura ecosystem. By bundling biometric data from the ring (sleep, heart rate, stress) with clinical workflows, Oura is attempting to unlock a closed-loop model where wearable insights directly inform medical decisions.

Strategic timing amid hardware pressure

The acquisition arrives as Oura confronts emerging rivals in the wearable ring category. RingConn and Ultrahuman have begun attracting users with competitive hardware and software features, eroding Oura’s historical market dominance. According to TechCrunch, the company is looking to expand its business model and help users access medical care—signaling that hardware differentiation alone is no longer sufficient.

Counsel’s addition transforms Oura from a wellness-monitoring tool into a primary-care entry point, potentially generating recurring revenue through subscription telemedicine and enterprise partnerships. Counsel Health raised $25 million in a Series A round led by Andreessen Horowitz (a16z) and GV approximately one year prior, according to TechCrunch. Counsel CEO Muthu Alagappan will assume the role of chief clinical AI officer at Oura, bringing approximately 70 employees to the parent company.

IPO postponement and capital redeployment

Oura postponed its planned IPO indefinitely in recent weeks, citing uncertainty in the IPO market, according to TechCrunch. The company had previously targeted a public offering valued at up to $2.2 billion. Rather than wait for market conditions to stabilize, Oura has deployed capital into the Counsel acquisition—a strategy that signals confidence in healthcare services as a growth vector while reducing exposure to volatile public markets.

The deal is expected to close before the end of 2027. Post-acquisition, Counsel will continue serving enterprise healthcare partners independent of Oura’s membership base, expanding the AI-native care model’s addressable market beyond the consumer ring user base.

Why this matters

For Oura, this acquisition represents a bet that clinical integration—not ring hardware alone—will determine market leadership in wearable health. Teams deciding between Oura and rivals like Ultrahuman will now weigh not just tracking accuracy but telemedicine convenience and medical AI reliability. For enterprises purchasing employee wellness programs, Oura’s inclusion of physician workflows may justify premium pricing over hardware-only competitors.

Counsel’s continued operation as an independent service suggests Oura is building optionality: if the integration succeeds, it scales inside Oura’s user base; if it falters, Counsel remains a standalone asset. However, the acquisition’s $625M price tag—roughly 17x Counsel’s reported Series A funding—assumes rapid customer acquisition and strong clinical unit economics, metrics that remain unproven in a market where telehealth margins remain compressed by competition from established players like Teladoc and Amwell.

Frequently Asked Questions

What does Counsel Health do?

Counsel Health is an AI-powered healthcare platform that delivers personalized medical guidance through an AI assistant, with on-demand access to licensed physicians for diagnosis and prescriptions.

How does this change the Oura experience?

Users can now access medical AI and physician consultations directly within the Oura app, connecting their biometric data (heart rate, sleep, recovery) with clinical decision-making.

Why is Oura acquiring Counsel Health now?

Oura faces increasing competition in the smart ring market from RingConn and Ultrahuman. The acquisition diversifies Oura beyond hardware into higher-margin, recurring clinical services.

What happened to Oura's IPO?

Oura postponed its planned IPO indefinitely in October 2026, citing uncertainty in the IPO market. The Counsel acquisition represents capital deployment while public markets remain unpredictable.

#healthcare #ai #wearables #acquisitions #telehealth